Gervasoni, Fabrizio LoMauro, Antonella Ricci, Vincenzo Salce, Gregorio Andreoli, Arnaldo Visconti, Alessandro Pantoni, Leonardo
Published in
Neurological Sciences
The symptoms of SARS-CoV-2 infection are not limited to the acute phase, with vertigo, peripheral neuropathies, headache, fatigue, memory loss, and depression being the most common post-acute clinical manifestations. Such post-COVID syndrome is a new clinically relevant challenge for diagnosis and therapy. Our goal was to quantify deficit in balanc...
Mosconi, Maria Giulia Caso, Francesco Maraziti, Giorgio Kremer, Christine Costa, Luisa Scarpa, Raffaele Giacomelli, Roberto Caso, Valeria
Published in
Neurological Sciences
Aiello, Edoardo Nicolò Esposito, Antonella Giannone, Ilaria Diana, Lorenzo Woolley, Susan Murphy, Jennifer Christodoulou, Georgia Tremolizzo, Lucio Bolognini, Nadia Appollonio, Ildebrando
...
Published in
Neurological Sciences
Background Up to 50% of motor neuron disease (MND) patients show neuropsychological deficits which negatively affect prognosis and care. However, disability-related logistical issues and uneven geographical coverage of healthcare services may prevent MND patients from accessing neuropsychological evaluations. This study thus aimed to standardize fo...
Cecchini, Maria Paola Brozzetti, Lorenzo Cardobi, Nicolò Sacchetto, Luca Gibellini, Davide Montemezzi, Stefania Cheli, Marta Manganotti, Paolo Monaco, Salvatore Zanusso, Gianluigi
...
Published in
Neurological Sciences
Objective It is reported that recovery from COVID-19 chemosensory deficit generally occurs in a few weeks, although olfactory dysfunction may persist longer. Here, we provide a detailed follow-up clinical investigation in a very young female patient (17-year-old) with a long-lasting anosmia after a mild infection, with partial recovery 15 months af...
Ibekwe, Elochukwu Kamdar, Hera A. Strohm, Tamara
Published in
Neurological Sciences
The objective of this manuscript is to describe the challenges of Cardio-Cerebral Infarction (CCI) treatment and to highlight the variable approaches in management. CCI is a rare clinical presentation of simultaneous acute ischemic stroke (AIS) and acute myocardial infarction (AMI) and poses a therapeutic challenge for practitioners. Each disease r...
Zheng, Shitan Wang, Juanjuan
Published in
Neurological Sciences
Alirezaei, Mohammad Eskandarieh, Sharareh Sahraian, Mohammad Ali Naser Moghadasi, Abdorreza
Published in
Neurological Sciences
Background Depression and anxiety are the two important factors determining quality of life of patients with multiple sclerosis (PWMS). In COVID-19 pandemic era, several factors can provoke mental issues of people and patients. In this cross-sectional study, we aim to estimate the new prevalence of anxious and depressive symptoms and their relating...
Santos García, Diego Cabo López, Iria Labandeira Guerra, Carmen Yáñez Baña, Rosa Cimas Hernando, Maria I. Paz González, Jose M. Alonso Losada, Maria G. Gonzalez Palmás, Maria J. Cores Bartolomé, Carlos Martínez Miró, Cristina
...
Published in
Neurological Sciences
Background and objective Some studies observed a benefit of PD patients after treatment with safinamide in some non-motor symptoms. Our aim was to analyze the effectiveness of safinamide on sleep and daytime sleepiness in Parkinson’s disease (PD) patients. Material and methods SAFINONMOTOR is a prospective open-label single-arm study conducted in 5...
Ercoli, Tommaso Masala, Carla Pinna, Ilenia Orofino, Gianni Solla, Paolo Rocchi, Lorenzo Defazio, Giovanni
Published in
Neurological Sciences
Background Qualitative smell/taste disorders (such as phantosmia, parosmia, phantogeusia, and parageusia) have not yet been fully characterized in patients who had COVID-19, whereas quantitative disturbances (i.e., reduction/loss of smell/taste) have been widely investigated. Objective To simultaneously assess the presence of both quantitative and ...
Wang, Haili Lu, Juan Zhao, Xia Qin, Rongyin Song, Kangping Xu, Yao Zhang, Jun Chen, Yingzhu
Published in
Neurological Sciences
Advanced age correlates with higher morbidity and mortality among patients affected with the novel coronavirus disease 2019 (COVID-19). Because systemic inflammation and neurological symptoms are also common in severe COVID-19 cases, there is concern that COVID-19 may lead to neurodegenerative conditions such as Alzheimer’s disease (AD). In this re...
